2024-10-30 REL RCSB RCSB RCSB 2022-01-12 2022-02-16 2022-02-16 2024-10-30 National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) AI145687 United States Manne K May A RBD antibody, DH1042, SARS, COVID-19, SARS-CoV-2 2P S ectodomain, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM complex Gobeil SM Henderson R Stalls V Janowska K Huang X May A Speakman M Beaudoin E Manne K Li D Parks R Barr M Deyton M Martin M Mansouri K Edwards RJ Eaton A Montefiori DC Sempowski GD Saunders KO Wiehe K Williams W Korber B Haynes BF Acharya P Mol.Cell US 82 2050 2068.e6 2022 35447081 doi:10.1016/j.molcel.2022.03.028 1097-2765 2168 MOCEFL Gobeil SM Henderson R Stalls V Janowska K Huang X May A Speakman M Beaudoin E Manne K Li D Parks R Barr M Deyton M Martin M Mansouri K Edwards RJ Sempowski GD Saunders KO Wiehe K Williams W Korber B Haynes BF Acharya P Biorxiv US 2022 35118469 doi:10.1101/2022.01.25.477784 2692-8205 7tht FULLOVERLAP Severe acute respiratory syndrome-related coronavirus spike glycoprotein in complex with RBD antibody DH1042 Severe acute respiratory syndrome-related coronavirus spike glycoprotein in complex with RBD antibody DH1042 0 1 Spike glycoprotein 1 1 Severe acute respiratory syndrome coronavirus 2 Antibody DH1042 1 2 3 Homo sapiens Spike glycoprotein Severe acute respiratory syndrome coronavirus 2 0.124125477 3 Homo sapiens LEVO AYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIF GTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNF KNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYY VGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR FASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLP DDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQ PYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILD ITPCSFGGVSVITPGTNTSNEVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPI GAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDS TECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKV TLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRF NGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDP PEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVT YVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELD S P0DTC2 DH1042 heavy chain Homo sapiens 0.013476164 3 Homo sapiens LEVO QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGRIIPMFGIANYAQKFQGRVTITADKSTSTAY LELSSLRSEDTAVYYCARYMVTRDQYYYDMDVWGQGTTVTVS DH1042 light chain Homo sapiens 0.011431628 3 Homo sapiens LEVO DIQMTQSPSSLSASVGDRVTITCRASQSISNYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQP EDFATYYCQQSYSPPPTFGQGTKLEI 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 33 NAG singleParticle particle 7.4 Quantifoil R1.2/1.3 COPPER 300 CARBON HOLEY GLOW DISCHARGE 30 AIR ETHANE FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 0.75 2.5 FEI TITAN KRIOS AUTOGRID HOLDER NITROGEN 93.15 93.15 GATAN K3 (6k x 4k) 14444 54.02 1 6VYB 3.42 FSC 0.143 CUT-OFF cryoSPARC 175460 MAXIMUM LIKELIHOOD cryoSPARC MAXIMUM LIKELIHOOD cryoSPARC cryoSPARC 6VYB C PDB experimental model 6VYB S PDB experimental model 6VYB V PDB experimental model 7EAN C 333-527 PDB experimental model 7EAN S 333-527 PDB experimental model 7EAN V PDB experimental model AB INITIO MODEL